NCT04169529View on ClinicalTrials.gov

Reveal LINQ for Chronic Obstructive Pulmonary Disease (COPD)

CompletedOBSERVATIONAL
Enrollment

42

Participants

Timeline

Start Date

August 25, 2020

Primary Completion Date

June 27, 2023

Study Completion Date

June 27, 2023

Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Interventions
DEVICE

Reveal LINQ

Insertion of Reveal LINQ device to characterize collected data from patients with COPD.

Trial Locations (9)

10075

Northwell Health Lenox Hill Hospital, New York

17604

Lancaster General Hospital, Lancaster

31404

Memorial Health University Medical Center, Savannah

32207

Baptist Medical Center, Jacksonville

33511

Bay Area Cardiology Associates, Brandon

34748

Clinical Site Partners Inc, Leesburg

43210

The Ohio State University, Columbus

73120

Oklahoma Cardiovascular Research Group, Oklahoma City

08053

Virtua Pulmonology Marlton, Marlton

All Listed Sponsors
lead

Medtronic Cardiac Rhythm and Heart Failure

INDUSTRY

NCT04169529 - Reveal LINQ for Chronic Obstructive Pulmonary Disease (COPD) | Biotech Hunter | Biotech Hunter